Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer

Clinical trial NCT00079612 · COMPLETED

Trial details

NCT number: NCT00079612
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2002-09-01
Enrollment: 501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.